The serum anti-Xa activity monitoring

The serum anti-Xa activity monitoring - The serum anti-Xa activity monitoring

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000020761

Enrollment

100

Registered

2016-04-01

Start date

2013-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atrial fibrillation

Interventions

blood sampling once &lt

10 cc during the period of the clinical trial

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with non-vitamin K antagonist oral anticoagulants

Exclusion criteria

Exclusion criteria: Equivalent to the drug indications

Design outcomes

Primary

Measure	Time frame
The relationship among the coagulation tests, bleeding events, and thrombogenic events	—

Countries

Japan

Contacts

Public ContactTakehiro Kimura

Keio University School of Medicine Department of Cardiology

kimura@z7.keio.jp0333531211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026